These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
4. Tacrine for treating Alzheimer's disease. Small GW JAMA; 1992 Nov; 268(18):2564-5. PubMed ID: 1404825 [No Abstract] [Full Text] [Related]
5. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease. Perryman KM; Fitten LJ Life Sci; 1993; 53(6):479-86. PubMed ID: 8341134 [TBL] [Abstract][Full Text] [Related]
6. The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials. Holford NH; Peace K Eur J Clin Pharmacol; 1994; 47(1):17-23. PubMed ID: 7988619 [TBL] [Abstract][Full Text] [Related]
7. Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity. Kaufer D; Cummings JL; Christine D J Neuropsychiatry Clin Neurosci; 1998; 10(1):55-63. PubMed ID: 9547467 [TBL] [Abstract][Full Text] [Related]
8. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related]
9. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective. Pendlebury WW; Solomon PR BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290 [No Abstract] [Full Text] [Related]
10. [Treatment of Alzheimer's disease]. Soininen H Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065 [No Abstract] [Full Text] [Related]
11. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Wagstaff AJ; McTavish D Drugs Aging; 1994 Jun; 4(6):510-40. PubMed ID: 7521234 [TBL] [Abstract][Full Text] [Related]
12. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. Chatellier G; Lacomblez L BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926 [TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of Alzheimer's disease. Schneider LS Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210 [No Abstract] [Full Text] [Related]
14. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia. Trzepacz PT; Ho V; Mallavarapu H Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507 [No Abstract] [Full Text] [Related]
15. Tacrine in Alzheimer's disease. Lachs M N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606 [No Abstract] [Full Text] [Related]
16. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]